Gainers
- Sonoma Pharmaceuticals SNOA shares rose 60.2% to $0.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.2 million. As per the press release, Q4 earnings came out 2 days ago.
- Mustang Bio MBIO stock moved upwards by 31.21% to $0.98. The market value of their outstanding shares is at $27.7 million.
- Geovax Labs GOVX shares increased by 24.32% to $1.38. The market value of their outstanding shares is at $3.4 million.
- Silk Road Medical SILK stock increased by 23.67% to $26.8. The company's market cap stands at $1.0 billion.
- Onconetix ONCO shares rose 18.91% to $0.19. The market value of their outstanding shares is at $4.2 million.
- Qualigen Therapeutics QLGN stock increased by 17.84% to $0.21. The market value of their outstanding shares is at $1.2 million.
Losers
- DermTech DMTK shares declined by 66.6% to $0.11 during Wednesday's pre-market session. The company's market cap stands at $3.8 million.
- Biolase BIOL stock fell 37.02% to $0.09. The market value of their outstanding shares is at $3.1 million.
- Zentalis Pharma ZNTL shares fell 25.51% to $6.25. The company's market cap stands at $443.8 million.
- Anitra AZTR shares decreased by 16.56% to $0.2. The company's market cap stands at $5.6 million.
- Virpax Pharmaceuticals VRPX stock fell 10.49% to $0.68. The market value of their outstanding shares is at $1.8 million.
- Longeveron LGVN stock decreased by 10.42% to $2.15. The company's market cap stands at $13.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BIOLBiolase Inc COM PAR $.001 NEW
$0.0174-%
GOVXGeovax Labs Inc
$2.27-2.13%
LGVNLongeveron Inc
$1.663.75%
MBIOMustang Bio Inc
$0.17968.78%
ONCOOnconetix Inc
$0.36431.19%
QLGNQualigen Therapeutics Inc
$4.01-0.74%
SNOASonoma Pharmaceuticals Inc
$2.49-2.35%
VRPXVirpax Pharmaceuticals Inc
$0.353811.8%
ZNTLZentalis Pharmaceuticals Inc
$3.002.39%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in